Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Methodology

The analysis of continuous data from n-of-1 trials using paired cycles: a simple tutorial

Author: Stephen Senn

Published in: Trials | Issue 1/2024

Login to get access

Abstract

N-of-1 trials are defined and the popular paired cycle design is introduced, together with an explanation as to how suitable sequences may be constructed.
Various approaches to analysing such trials are explained and illustrated using a simulated data set. It is explained how choosing an appropriate analysis depends on the question one wishes to answer. It is also shown that for a given question, various equivalent approaches to analysis can be found, a fact which may be exploited to expand the possible software routines that may be used.
Sets of N-of-1 trials are analogous to sets of parallel group trials. This means that software for carrying out meta-analysis can be used to combine results from N-of-1 trials. In doing so, it is necessary to make one important change, however. Because degrees of freedom for estimating variances for individual subjects will be scarce, it is advisable to estimate local standard errors using pooled variances. How this may be done is explained and fixed and random effect approaches to combining results are illustrated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, et al. A clinician’s guide for conducting randomized trials in individual patients. Cmaj. 1988;139:497–503.PubMedPubMedCentral Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, et al. A clinician’s guide for conducting randomized trials in individual patients. Cmaj. 1988;139:497–503.PubMedPubMedCentral
2.
3.
go back to reference Ludbrook J, Dudley H. Why permutation tests are superior to t and F tests in biomedical research. Am Statist. 1998;52:127–32. Ludbrook J, Dudley H. Why permutation tests are superior to t and F tests in biomedical research. Am Statist. 1998;52:127–32.
4.
go back to reference Dugard P, File P, Todman J, Todman JB. Single-case and small-n experimental designs: a practical guide to randomization tests. Second ed. Routledge; 2012.CrossRef Dugard P, File P, Todman J, Todman JB. Single-case and small-n experimental designs: a practical guide to randomization tests. Second ed. Routledge; 2012.CrossRef
5.
go back to reference Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991;18:447–51.PubMed Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991;18:447–51.PubMed
6.
go back to reference Zucker DR, Schmid CH, McIntosh MW, D’Agostino RB, Selker HP, Lau J. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J clin epidemiol. 1997;50:401–10.CrossRefPubMed Zucker DR, Schmid CH, McIntosh MW, D’Agostino RB, Selker HP, Lau J. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J clin epidemiol. 1997;50:401–10.CrossRefPubMed
7.
go back to reference Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J clin epidemiol. 2010;63:1312–23.CrossRefPubMedPubMedCentral Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J clin epidemiol. 2010;63:1312–23.CrossRefPubMedPubMedCentral
9.
go back to reference Senn SJ. Cross-over trials in clinical research. Second ed. Chichester: Wiley; 2002.CrossRef Senn SJ. Cross-over trials in clinical research. Second ed. Chichester: Wiley; 2002.CrossRef
10.
go back to reference Vohra S, Shamseer L, Sampson M, Bukutu C, Schmid CH, Tate R, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ. 2015;350:h1738.CrossRefPubMed Vohra S, Shamseer L, Sampson M, Bukutu C, Schmid CH, Tate R, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ. 2015;350:h1738.CrossRefPubMed
11.
go back to reference Senn SJ. Added values: controversies concerning randomization and additivity in clinical trials. Statist Med. 2004;23:3729–53.CrossRef Senn SJ. Added values: controversies concerning randomization and additivity in clinical trials. Statist Med. 2004;23:3729–53.CrossRef
12.
go back to reference Conover WJ, Salsburg DS. Locally most powerful tests for detecting treatment effects when only a subset of patients can be expected to respond to treatment. Biometrics. 1988;44:189–96.MathSciNetCrossRefPubMed Conover WJ, Salsburg DS. Locally most powerful tests for detecting treatment effects when only a subset of patients can be expected to respond to treatment. Biometrics. 1988;44:189–96.MathSciNetCrossRefPubMed
13.
go back to reference Whitehead A. Meta-analysis of controlled clinical trials. Chichester: Wiley; 2002.CrossRef Whitehead A. Meta-analysis of controlled clinical trials. Chichester: Wiley; 2002.CrossRef
14.
go back to reference Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.CrossRef Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.CrossRef
15.
go back to reference Schwarzer G, Carpenter JR, Rücker G. Meta-analysis with R. Springer; 2015.CrossRef Schwarzer G, Carpenter JR, Rücker G. Meta-analysis with R. Springer; 2015.CrossRef
16.
go back to reference Senn SJ. Letter to the Editor: in defence of the linear model. Controlled clinical trials. 2000;21:589–92.CrossRefPubMed Senn SJ. Letter to the Editor: in defence of the linear model. Controlled clinical trials. 2000;21:589–92.CrossRefPubMed
17.
go back to reference Senn S, Schmitz S, Schritz A, Araujo A. A note regarding alternative explanations for heterogeneity in meta-analysis. Stat Med. 2022;41:4501–9.MathSciNetCrossRefPubMed Senn S, Schmitz S, Schritz A, Araujo A. A note regarding alternative explanations for heterogeneity in meta-analysis. Stat Med. 2022;41:4501–9.MathSciNetCrossRefPubMed
18.
go back to reference Schwarzer G. meta: an R package for meta-analysis. R news. 2007;7:40–5. Schwarzer G. meta: an R package for meta-analysis. R news. 2007;7:40–5.
19.
20.
21.
go back to reference Galwey NW. Introduction to mixed modelling: beyond regression and analysis of variance. John Wiley & Sons; 2014.CrossRef Galwey NW. Introduction to mixed modelling: beyond regression and analysis of variance. John Wiley & Sons; 2014.CrossRef
23.
go back to reference Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Statist Softw. 2010;36:1–48.CrossRef Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Statist Softw. 2010;36:1–48.CrossRef
24.
go back to reference Brown H, Prescott R. Applied mixed models in medicine. 3rd ed. Chichester: John Wiley & Sons; 2014.CrossRef Brown H, Prescott R. Applied mixed models in medicine. 3rd ed. Chichester: John Wiley & Sons; 2014.CrossRef
25.
go back to reference Gałecki A, Burzykowski T. Linear mixed-effects models using R: a step-by-step approach. Springer Science & Business Media; 2013.CrossRef Gałecki A, Burzykowski T. Linear mixed-effects models using R: a step-by-step approach. Springer Science & Business Media; 2013.CrossRef
26.
go back to reference Van Den Noortgate W, Onghena P. Estimating the mean effect size in meta-analysis: bias, precision, and mean squared error of different weighting methods. Behav Res Methods Instrum Comput. 2003;35:504–11.CrossRefPubMed Van Den Noortgate W, Onghena P. Estimating the mean effect size in meta-analysis: bias, precision, and mean squared error of different weighting methods. Behav Res Methods Instrum Comput. 2003;35:504–11.CrossRefPubMed
27.
go back to reference Senn SJ. Statistical issues in drug development. 3rd ed. Chichester: John Wiley & Sons; 2021.CrossRef Senn SJ. Statistical issues in drug development. 3rd ed. Chichester: John Wiley & Sons; 2021.CrossRef
28.
go back to reference Jones B, Kenward MG. Design and analysis of cross-over trials. 3rd ed. Boca Raton: CRC Press; 2015. Jones B, Kenward MG. Design and analysis of cross-over trials. 3rd ed. Boca Raton: CRC Press; 2015.
29.
go back to reference Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd; 1935. Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd; 1935.
30.
go back to reference Siegfried S, Senn S, Hothorn T. On the relevance of prognostic information for clinical trials: a theoretical quantification. Biom J. 2023;65 Siegfried S, Senn S, Hothorn T. On the relevance of prognostic information for clinical trials: a theoretical quantification. Biom J. 2023;65
31.
go back to reference Julious SA. Why do we use pooled variance analysis of variance? Pharm Stat. 2005;4:3–5.CrossRef Julious SA. Why do we use pooled variance analysis of variance? Pharm Stat. 2005;4:3–5.CrossRef
33.
go back to reference VSN International. Genstat for Windows. 24th ed. Hemel Hempstead UK: VSN International; 2024. VSN International. Genstat for Windows. 24th ed. Hemel Hempstead UK: VSN International; 2024.
34.
go back to reference Araujo A. Statistical Issues in the Design and Analysis of Series of N-of-1 Trials. GitHub - arturstat/nof1_issues: Statistical Issues in the Design and Analysis of Series of N-of-1 Trials. Accessed 14 Feb 2024. Araujo A. Statistical Issues in the Design and Analysis of Series of N-of-1 Trials. GitHub - arturstat/nof1_issues: Statistical Issues in the Design and Analysis of Series of N-of-1 Trials. Accessed 14 Feb 2024.
Metadata
Title
The analysis of continuous data from n-of-1 trials using paired cycles: a simple tutorial
Author
Stephen Senn
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-07964-7

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue